Celera Q4 and Yearly Revenues Surge on New Subscriptions, Collaborations | GenomeWeb

NEW YORK, July 26 – Celera Genomics on Thursday posted fiscal fourth-quarter revenues of $27.4 million, compared with $15 million in the year ago period.

For the year, the company’s revenues more than doubled, reaching $89.4 million, compared with $42.7 million in fiscal year 2000. Celera attributed the increase to a host of new subscriptions to its Celera Discovery Systems as well as to a number of collaborations and service agreements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.